Clinical Director
Noema Pharma AG · Daiichi Sankyo · Merck Sharp & Dohme LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Clinical Director as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:49 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT06385795 · A Study of NOE-115 in Women With Vasomotor Symptoms Due to MenopauseNoema Pharma AG · completed · Menopause Syndrome, Menopause, Hot Flashes · study director
- Ph2NCT06315751 · Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette SyndromeNoema Pharma AG · active not recruiting · Tourette Syndrome · study director
- Ph3NCT06203210 · A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung CancerDaiichi Sankyo · recruiting · Small Cell Lung Cancer · study director
- N/ANCT06019338 · A Study to Validate a Pain Diary for Patient With Trigeminal NeuralgiaNoema Pharma AG · completed · Trigeminal Neuralgia · study director
- Ph3NCT05696080 · Safety and Immunogenicity of V116 in Adults With Increased Risk for Pneumococcal Disease (V116-008)Merck Sharp & Dohme LLC · completed · Pneumococcal Infection · study director
- Ph1NCT05583669 · A Study to Assess the Safety and Pharmacokinetics of Multiple Ascending Subcutaneous Doses of DS-2325a in Healthy SubjectsDaiichi Sankyo · completed · Netherton Syndrome · study director
- Ph2NCT05569252 · A Study of DS-1211b in Individuals With PseudoXanthoma ElasticumDaiichi Sankyo · completed · Pseudoxanthoma Elasticum · study director
- Ph4NCT05400369 · A Study to Evaluate the Efficacy and Safety of Sitafloxacin in Adult Subjects With Acute Exacerbation of Chronic Obstructive Pulmonary DiseaseDaiichi Sankyo · completed · COPD Exacerbation Acute · study director
- Ph1NCT05394675 · A Study of DS-9606a in Patients With Advanced Solid TumorsDaiichi Sankyo · terminated · Advanced Cancer, Metastatic Cancer, Germ Cell Tumor · study director
- Ph1NCT05388903 · A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy SubjectsDaiichi Sankyo · completed · Netherton Syndrome · study director
- Ph2NCT05059327 · Basimglurant (NOE-101) in Children, Adolescents, and Young Adults With TSCNoema Pharma AG · completed · Tuberous Sclerosis Complex · study director
- N/ANCT04594915 · Evaluation of Treatment Safety in Patients With Atrial Fibrillation on Edoxaban Therapy in Real-Life in TurkeyDaiichi Sankyo Turkey, a Daiichi Sankyo Company · completed · Atrial Fibrillation · study director
- N/ANCT03274999 · Clinical Study to Evaluate Tear Characteristics Following Acute TrueTear™ UseAllergan · terminated · Dry Eye Syndromes · study director
- N/ANCT03272100 · Influence of Two Different Flap Designs for Sinus Floor ElevationUniversity of Firenze and Siena, Napoli, Italy · completed · Bone Involvement in Diseases Classified Elsewhere · study chair
- Ph3NCT02584478 · Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002)Advenchen Laboratories, LLC · unknown · Endometrial Carcinoma, Ovarian Carcinoma, Fallopian Tube Carcinoma · study director
- Ph1/Ph2NCT02558348 · Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)Advenchen Laboratories, LLC · terminated · Endometrial Cancer, Ovarian Cancer, Cervical Cancer · study director
- Ph4NCT01857297 · A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy VolunteersSeqirus · completed · Influenza, Human · study director
- Ph1NCT01620801 · Hemophilia B Gene Therapy With AAV8 VectorSpark Therapeutics, Inc. · terminated · Hemophilia B · study director
- Ph4NCT01591837 · A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy VolunteersSeqirus · completed · Influenza, Human · study director
- Ph1NCT01391663 · Pharmacokinetics and Pharmacodynamics Study of Alogliptin in Healthy Korean ParticipantsTakeda · completed · Pharmacokinetics and Pharmacodynamics · study director
- Ph1/Ph2NCT01208389 · Phase 1 Follow-on Study of AAV2-hRPE65v2 Vector in Subjects With Leber Congenital Amaurosis (LCA) 2Spark Therapeutics, Inc. · active not recruiting · Leber Congenital Amaurosis · study director
- Ph1NCT01109758 · Effects of Fenofibrate on Gene Expression in Healthy VolunteersSolvay Pharmaceuticals · completed · Healthy · study director
- Ph1NCT00998933 · Study of Serum Testosterone Levels in Non-dosed Females After Secondary ExposureSolvay Pharmaceuticals · completed · Hypogonadism · study director
- Ph3
- Ph2NCT00958243 · A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USASeqirus · completed · Influenza · study director
- Ph2NCT00940108 · A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy ChildrenSeqirus · completed · Influenza Caused by the Novel Influenza A (H1N1) Virus · study director
- Ph1NCT00924430 · Interaction Study SLV337/SimvastatinSolvay Pharmaceuticals · completed · Type 2 Diabetes Mellitus · study director
- Ph4NCT00888381 · A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy VolunteersSeqirus · completed · Influenza · study director
- Ph1NCT00885989 · Safety and Tolerability of the First IV Dosing of SLV338 in Healthy VolunteersSolvay Pharmaceuticals · completed · Healthy · study director
- Ph2NCT00816829 · Effect of Fenofibrate on Sleep Apnea SyndromeSolvay Pharmaceuticals · terminated · Dyslipidemia, Sleep Apnea Syndrome, Overweight · study director
- Ph3NCT00775528 · Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency Due to Cystic FibrosisSolvay Pharmaceuticals · completed · Cystic Fibrosis, Pancreatic Exocrine Insufficiency · study director
- Ph4NCT00735475 · A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared to a US Licensed Comparator Influenza Virus VaccineSeqirus · completed · Influenza · study director
- N/ANCT00727259 · Evaluation of Satisfaction in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C (Study P04067)Merck Sharp & Dohme LLC · completed · Hepatitis C, Chronic · study director
- Ph2NCT00703482 · A Randomised, Double-Blind, Placebo-Controlled Study Assessing the Effect of Fenofibrate, Coenzyme Q10 and Their co-Administration on Ventricular Diastolic Function in Patients With Type 2 DiabetesSolvay Pharmaceuticals · completed · Patients With Type 2 Diabetes · study director
- Ph2NCT00703755 · A Randomized, Double-Blind Trial Comparing the Efficacy and Safety of Fenofibrate, Metformin, Their Combination and Placebo in Patients With Metabolic Syndrome.Solvay Pharmaceuticals · completed · Patients With Metabolic Syndrome · study director
- Ph3NCT00690820 · Study Investigating a Delayed-Release Pancrelipase in Patients With Pancreatic Exocrine Insufficiency (PEI) Due to Cystic Fibrosis (CF)Solvay Pharmaceuticals · completed · Cystic Fibrosis, Pancreatic Exocrine Insufficiency · study director
- Ph2NCT00679718 · A Study of INS365 Ophthalmic Solution in Patients With Moderate to Severe Dry Eye DiseaseMerck Sharp & Dohme LLC · completed · Dry Eye Disease · study director
- Ph2NCT00680108 · A Study to Determine the Safety and Tolerability of Escalating Doses of INS365 Ophthalmic SolutionMerck Sharp & Dohme LLC · completed · Dry Eye Disease · study director
- Ph3NCT00665509 · Annual Study to Investigate Inactivated Subunit Influenza Vaccine Due to New Virus Strains for the 08/09 Season.Solvay Biologicals · completed · Influenza · study director
- Ph3NCT00642512 · Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and VomitingSolvay Pharmaceuticals · completed · Chemotherapy Induced Nausea and Vomiting · study director
- Ph2NCT00642499 · Dronabinol Versus Placebo in Treatment and Prevention of Highly Active Anti-Retroviral Therapy (HAART)-Related Nausea and VomitingSolvay Pharmaceuticals · completed · Highly Active Antiretroviral Therapy (HAART)-Related Nausea and Vomiting, HIV Infections · study director
- Ph2NCT00630279 · Dose-ranging Study to Evaluate Efficacy of SLV339 in Pancreatic Exocrine Insufficiency Due to Chronic PancreatitisSolvay Pharmaceuticals · terminated · Pancreatic Exocrine Insufficiency Due to Chronic Pancreatitis · study director
- Ph4NCT00598910 · Effect of Omacor on Triglycerides in HIV Infected SubjectsSolvay Pharmaceuticals · terminated · Hyper-Triglyceridemia · study director
- Ph1NCT00599443 · Safety and Tolerability of a Cell-Derived Influenza Vaccine in Healthy Adults Aged ≥18 Years and ≤ 49 YearsSolvay Pharmaceuticals · completed · Healthy · study director
- N/ANCT00568009 · Study to Evaluate the Effect of SLV320 in Addition to Chronic Furosemide Treatment on Renal Function in Subjects With Congestive Heart Failure and Impaired Renal FunctionSolvay Pharmaceuticals · terminated · Congestive Heart Failure · study director
- Ph4NCT00562484 · A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Administered Intramuscularly in Healthy AdultsSeqirus · completed · Influenza · study director
- Ph1NCT00562237 · Immunogenicity and Safety of Two Adjuvant Formulations of an Egg-Derived Pandemic VaccineSolvay Pharmaceuticals · terminated · Healthy Subjects · study director
- Ph1NCT00543647 · Effect of Fenofibrate on Kidney Function: a Six-week Randomized Cross-over Trial in Healthy PeopleSolvay Pharmaceuticals · completed · Healthy Volunteers · study director
- Ph2/Ph3NCT00541567 · BMS-646256 in Obese and Overweight Type 2 DiabeticsSolvay Pharmaceuticals · withdrawn · Obesity and Type 2 Diabetes · study director
- Ph1NCT00516477 · Safety Study in Subjects With Leber Congenital AmaurosisSpark Therapeutics, Inc. · completed · Leber Congenital Amaurosis · study director
- N/ANCT00515710 · LTFU for Gene Transfer Subjects With Hemophilia BSpark Therapeutics, Inc. · completed · Hemophilia B · study director
- Ph3NCT00510484 · Study Investigating a Delayed-Release Pancrelipase in Patients With Exocrine Pancreatic Insufficiency Due to Cystic FibrosisSolvay Pharmaceuticals · completed · Cystic Fibrosis · study director
- Ph3NCT00490178 · Acceptability Study of a New Fixed Combination of Fenofibrate 80 mg BID and Metformin 1000 mg BID in Type 2 Diabetes and DyslipidemiaSolvay Pharmaceuticals · completed · Diabetes Mellitus, Type 2, Dyslipidemia · study director
- Ph3NCT00479921 · Annual Study to Investigate Influenza Vaccine Due to New Virus Strains for the 2007/2008 Influenza Season in EuropeSolvay Pharmaceuticals · completed · Healthy Volunteers · study director
- Ph1NCT00462761 · A Phase I Study of AC220 in Patients With Relapsed/Refractory Acute Myeloid Leukemia Regardless of FLT3 StatusDaiichi Sankyo · completed · Acute Myeloid Leukemia, Leukemia, Myelodysplastic Syndrome · study director
- Ph3NCT00433199 · Testosterone Treatment for Hypogonadal MenAbbott · completed · Hypogonadism · study director
- Ph3NCT00414908 · A Study to Investigate the Effect of Delayed Release Pancrelipase on Maldigestion in Patients With Exocrine Pancreatic Insufficiency Due to Chronic Pancreatitis and PancreatectomySolvay Pharmaceuticals · completed · Chronic Pancreatitis, Pancreatectomy, Pancreatic Exocrine Insufficiency · study director
- Ph3NCT00406588 · SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor FluctuationsSolvay Pharmaceuticals · completed · Advanced Stage Parkinson's Disease · study director
- Ph3NCT00396214 · Compare the Effects of Bifeprunox and Quetiapine on Weight Changes in Stable Schizophrenic PatientsSolvay Pharmaceuticals · terminated · Schizophrenia · study director
- Ph3NCT00362934 · Comparison of the Combination of Fenofibrate and Simvastatin Versus AtorvastatinSolvay Pharmaceuticals · completed · Hyperlipidemia · study director
- Ph2/Ph3NCT00362765 · Fenofibrate and Metformin Insulin Sensitivity in Type 2 Diabetics StudySolvay Pharmaceuticals · terminated · Type 2 Diabetes, Dyslipidemia · study director
- Ph3NCT00361868 · Fenofibrate and Metformin Fixed Combination vs Rosiglitazone - FAME ROSISolvay Pharmaceuticals · terminated · Dyslipidemia, Glucose Metabolism Disorder · study director
- Ph3NCT00362206 · Comparison of the Combination of Fenofibrate and Simvastatin Versus PravastatinSolvay Pharmaceuticals · completed · Hyperlipidemia · study director
- Ph3NCT00352183 · Comparison of the Combination of Fenofibrate and 40 mg Simvastatin Versus 40 mg Simvastatin MonotherapySolvay Pharmaceuticals · completed · Cardiovascular Diseases · study director
- Ph2NCT00349635 · A Controlled-Study on the Effect of a Combination of Fenofibrate and Metformin on Weight Loss and Weight Loss-Maintenance, in Obese Patients.Solvay Pharmaceuticals · completed · Obesity · study director
- Ph3NCT00349375 · Comparison of the Combination of Fenofibrate and 20 mg Simvastatin Versus 40 mg Simvastatin MonotherapySolvay Pharmaceuticals · completed · Hyperlipidemia · study director
- Ph2/Ph3NCT00349128 · Fenofibrate in Dyslipidemia and Metformin-Controlled DiabetesSolvay Pharmaceuticals · completed · Dyslipidemia/Glucose Metabolism Disorder · study director
- Ph3NCT00349284 · A Controlled-Study of Fenofibrate 145 mg and Ezetimibe 10 mg in Type IIb Dyslipidemic Patients With Features of the Metabolic SyndromeSolvay Pharmaceuticals · completed · Hyperlipidemia Combined · study director
- Ph3NCT00348725 · Acceptability of a Fixed Combination of Fenofibrate and MetforminSolvay Pharmaceuticals · completed · Dyslipidemia/Glucose Metabolism Disorder · study director
- Ph3NCT00347425 · Switch Study of Existing Atypical Antipsychotics to BifeprunoxSolvay Pharmaceuticals · completed · Schizophrenia and Schizoaffective Disorder · study director
- Ph3NCT00346723 · Annual Study to Investigate Inactivated Subunit Influenza Vaccine for the 2006/2007 Influenza Season in Europe.Solvay Pharmaceuticals · completed · Healthy Volunteers · study director
- Ph3NCT00345462 · Annual Study to Investigate Inactivated Virosomal Influenza Vaccine for the 2006/2007 Influenza Season in Europe.Solvay Pharmaceuticals · withdrawn · Healthy Volunteers · study director
- Ph3NCT00335374 · An Open Label SLV308 Safety Extension to Study S308.3.003 in Early PD PatientsSolvay Pharmaceuticals · completed · Early Stage Parkinson's Disease · study director
- Ph3NCT00335166 · SLV 308 and Pramipexole for Treatment of Patients With Early Parkinson DiseaseSolvay Pharmaceuticals · completed · Early Stage Parkinson Disease · study director
- Ph3NCT00332917 · An Open Label SLV308 Safety Extension to Study S308.3.001 in Early PD PatientsSolvay Pharmaceuticals · completed · Early Stage Parkinson's Disease · study director
- Ph3NCT00325260 · Non-Inferiority Study Comparing the Subunit Vaccines Influvac and Agrippal in ChinaSolvay Pharmaceuticals · completed · Healthy · study director
- Ph3NCT00269516 · SLV308 for Treatment of Patients With Early Parkinson's DiseaseSolvay Pharmaceuticals · completed · Early Stage Parkinson's Disease · study director
- Ph3NCT00264225 · Analgesic Effectiveness of Three Different Doses of a New Formulation of Lamaline in a Model of Painful Knee (Gonarthrosis)Solvay Pharmaceuticals · completed · Knee Osteoarthritis · study director
- Ph3NCT00251082 · Vasomotoric Symptoms Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone CombinationSolvay Pharmaceuticals · completed · Postmenopause · study director
- Ph2NCT00244452 · A Multinational, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Investigate the Efficacy, Safety and Duration of Effect of a Single Administration of Various Doses of Cetrorelix SR in Subjects With Histologically Confirmed EndometriosisSolvay Pharmaceuticals · completed · Endometriosis · study director
- Ph3NCT00230828 · Patient-reported Outcomes in the Treatment of SchizophreniaSolvay Pharmaceuticals · completed · Schizophrenia · study director
- Ph3NCT00193687 · Bifeprunox in the Treatment of SchizophreniaSolvay Pharmaceuticals · completed · Schizophrenia · study director
- Ph3NCT00193713 · Bifeprunox in the Treatment of SchizophreniaSolvay Pharmaceuticals · completed · Schizophrenia · study director
- Ph1NCT00193700 · Pharmacokinetic Evaluation of Testosterone Gel (1%)Solvay Pharmaceuticals · completed · Primary or Secondary Hypogonadism, Constitutional Delay in Growth and Puberty (CDGP) · study director
- Ph2NCT00193661 · Observation Study of T-Gel (1%) in Treatment of Adolescent Boys With HypogonadismSolvay Pharmaceuticals · completed · Primary or Secondary Hypogonadism, Constitutional Delay in Growth and Puberty (CDGP) · study director
- Ph4NCT00160173 · Efficacy Study Comparing 0.9 g and 1.25 g Estrogel With Placebo for Vasomotor Symptoms and Vulvar and Vaginal AtrophyASCEND Therapeutics · completed · Postmenopausal Symptoms · study director
- Ph2NCT00160342 · Comparison of Estrogen and Methyltestosterone Combination Treatments for Postmenopausal Hot FlushesSolvay Pharmaceuticals · completed · Hot Flushes, Menopause, Postmenopause · study director
- N/ANCT00160160 · Comparison of Eprosartan/HCT Versus Enalapril/HCT in Hypertensives With Type II DiabetesSolvay Pharmaceuticals · completed · Hypertension, Type 2 Diabetes · study director
- Ph2NCT00160212 · Study to Evaluate the Efficacy and Safety of SLV306 in Subjects With HypertensionSolvay Pharmaceuticals · completed · Hypertension · study director
- Ph4NCT00160186 · Gastrectomy Study: Study to Investigate the Effect of Creon 25000 Minimicrospheres on Body Mass Index (BMI) in Patients After GastrectomySolvay Pharmaceuticals · completed · Gastrectomy · study director
- Ph2NCT00160225 · Study to Evaluate the Efficacy and Safety of Daglutril Compared to Placebo on Top of Losartan in Type 2 Diabetics With Overt Nephropathy and Well Controlled HypertensionSolvay Pharmaceuticals · completed · Hypertension · study director
- Ph3NCT00160316 · Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone CombinationSolvay Pharmaceuticals · completed · Postmenopause · study director
- Ph3NCT00160147 · Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's TypeSolvay Pharmaceuticals · terminated · Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type · study director
- Ph4NCT00160199 · Safety and Efficacy of PROMETRIUM® Capsules in Induction of Secretory ConversionSolvay Pharmaceuticals · completed · Secondary Amenorrhea · study director
- Ph3NCT00160277 · Efficacy and Safety of Moxonidine in Indian PatientsSolvay Pharmaceuticals · completed · Hypertension · study director
- Ph4NCT00160238 · Effects of Betaserc on Vestibular Compensation in Patients Suffering From Disabling Meniere's Disease and Having Undergone Vestibular NeurotomySolvay Pharmaceuticals · completed · Meniere's Disease · study director
- Ph4NCT00160264 · Study to Investigate if Adding Lactulose to Vitamin D and Calcium Has an Effect on the Preservation of Bone in Postmenopausal WomenSolvay Pharmaceuticals · completed · Osteopenia · study director
- Ph2NCT00160134 · Study to Evaluate Cardiac Hemodynamics and Safety of SLV320 in Subjects With Congestive Heart FailureSolvay Pharmaceuticals · completed · Congestive Heart Failure · study director
- Ph4NCT00160290 · Trial to Evaluate Effect of Lactulose on Hard Stools in Patients With Hemorrhoids or Anal FissuresSolvay Pharmaceuticals · terminated · Hemorrhoids, Anal Fissures · study director
- Ph4NCT00145522 · Study to Compare the Effect of Hormone Replacement Therapy (HRT) on Breast and Cardiovascular Metabolic Markers in Postmenopausal WomenSolvay Pharmaceuticals · completed · Menopause · study director
- Ph2NCT00141544 · The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Non-Hysterectomized Postmenopausal WomenSolvay Pharmaceuticals · terminated · Menopause · study director
- Ph2NCT00141557 · The Efficacy of ESTRATEST® Tablets in Relieving Menopausal Symptoms in Estrogenized, Hysterectomized Postmenopausal WomenSolvay Pharmaceuticals · terminated · Menopause · study director
- Ph2NCT00141570 · Study of the Efficacy of ESTRATEST® H.S. Tablets in Relieving Menopausal Symptoms in Estrogenized Postmenopausal WomenSolvay Pharmaceuticals · completed · Menopause · study director
- Ph2NCT00141492 · Efficacy and Safety of Androgel in the Treatment of Hypogonadal and Low Testosterone Men With Type 2 DiabetesSolvay Pharmaceuticals · completed · Type 2 Diabetes, Hypogonadism · study director
- Ph2NCT00141505 · PK Effects of Bifeprunox & Valproate in Bipolar ISolvay Pharmaceuticals · completed · Bipolar I Disorder · study director
- Ph2NCT00141479 · To Evaluate the Impact of Treatment Interruption on Re-initiation of BifeprunoxSolvay Pharmaceuticals · completed · Schizophrenia, Schizoaffective Disorder · study director
- Ph2NCT00139919 · Progressively Decreasing Titration Schedules of Bifeprunox in Subjects With Schizophrenia or Bipolar DisorderSolvay Pharmaceuticals · completed · Schizophrenia, Schizoaffective Disorder, Bipolar Disorder · study director
- Ph2NCT00139906 · Twice Daily Titration Study of Bifeprunox in Subjects With SchizophreniaSolvay Pharmaceuticals · completed · Schizophrenia, Schizoaffective Disorder · study director
- Ph3NCT00134251 · Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's DiseaseSolvay Pharmaceuticals · completed · Parkinson's Disease · study director
- Ph3NCT00126074 · Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsSolvay Pharmaceuticals · completed · Atrial Fibrillation, Atrial Flutter · study director
- Ph3NCT00126061 · Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Male SubjectsSolvay Pharmaceuticals · completed · Atrial Fibrillation, Atrial Flutter · study director
- Ph3NCT00126022 · Intravenous Tedisamil in the Rapid Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm in Female SubjectsSolvay Pharmaceuticals · completed · Atrial Fibrillation, Atrial Flutter · study director
- Ph2NCT00123201 · Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine HeadacheSolvay Pharmaceuticals · completed · Migraine With Aura, Migraine Without Aura · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:49 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.